3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
5
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Pain
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Flushing
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Driving Under the Influence
1
Depression
1
Colorectal Neoplasms
1
Carney Complex
1
Cardiovascular Diseases
1
Binge-Eating Disorder
1
Binge Drinking
1
Alzheimer Disease
1
Agnosia
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
4
Vemurafenib
4
selpercatinib
3
dabrafenib
3
Specimen Handling
3
entrectinib
2
cobimetinib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
tovorafenib
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
copanlisib
1
Whole Body Imaging
1
Transurethral Resection of Prostate
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Sodium Iodide
1
Robotic Surgical Procedures
1
Postoperative Period
1
Phantoms, Imaging
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
Ethanol
×
1 year
×
Clear all
No trials found.